These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27626293)

  • 1. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
    Manjunatha UH; Chao AT; Leong FJ; Diagana TT
    ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
    Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
    Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic screening techniques for
    Love MS; McNamara CW
    Expert Opin Drug Discov; 2021 Jan; 16(1):59-74. PubMed ID: 32892652
    [No Abstract]   [Full Text] [Related]  

  • 4. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in therapeutic and vaccine targets for Cryptosporidium: Challenges and possible mitigation strategies.
    Rahman SU; Mi R; Zhou S; Gong H; Ullah M; Huang Y; Han X; Chen Z
    Acta Trop; 2022 Feb; 226():106273. PubMed ID: 34906550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in genetic manipulation of Cryptosporidium.
    Vinayak S
    Curr Opin Microbiol; 2020 Dec; 58():146-152. PubMed ID: 33161368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
    Giacometti A; Burzacchini F; Cirioni O; Barchiesi F; Dini M; Scalise G
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):885-9. PubMed ID: 10691200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Breakthroughs and Ongoing Limitations in
    Bhalchandra S; Cardenas D; Ward HD
    F1000Res; 2018; 7():. PubMed ID: 30228873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis.
    Lunde CS; Stebbins EE; Jumani RS; Hasan MM; Miller P; Barlow J; Freund YR; Berry P; Stefanakis R; Gut J; Rosenthal PJ; Love MS; McNamara CW; Easom E; Plattner JJ; Jacobs RT; Huston CD
    Nat Commun; 2019 Jun; 10(1):2816. PubMed ID: 31249291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel treatment strategies and drugs in development for cryptosporidiosis.
    Chavez MA; White AC
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma.
    Chellan P; Sadler PJ; Land KM
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1491-1501. PubMed ID: 28242275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model.
    Stebbins E; Jumani RS; Klopfer C; Barlow J; Miller P; Campbell MA; Meyers MJ; Griggs DW; Huston CD
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006183. PubMed ID: 29309415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging therapeutic avenues against Cryptosporidium: A comprehensive review.
    Ali M; Xu C; Wang J; Kulyar MF; Li K
    Vet Parasitol; 2024 Oct; 331():110279. PubMed ID: 39116547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.
    Nachipo P; Hermann D; Quinnan G; Gordon MA; Van Voorhis WC; Iroh Tam PY
    Trials; 2018 Aug; 19(1):456. PubMed ID: 30139372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better.
    Caravedo MA; White AC
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):167-173. PubMed ID: 36533398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia?
    Kelly P
    Parasitology; 2011 Oct; 138(12):1488-91. PubMed ID: 21320387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.
    Lee S; Ginese M; Beamer G; Danz HR; Girouard DJ; Chapman-Bonofiglio SP; Lee M; Hulverson MA; Choi R; Whitman GR; Ojo KK; Arnold SLM; Van Voorhis WC; Tzipori S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoite.
    Edwinson A; Widmer G; McEvoy J
    Int J Parasitol; 2016 Jan; 46(1):67-74. PubMed ID: 26432292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
    Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors.
    Jumani RS; Hasan MM; Stebbins EE; Donnelly L; Miller P; Klopfer C; Bessoff K; Teixeira JE; Love MS; McNamara CW; Huston CD
    Nat Commun; 2019 Apr; 10(1):1862. PubMed ID: 31015448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.